Biognosys

Switzerland
Schlieren, Zurich, Switzerland, 8952

Company profile

Biognosys company profile

Biognosys believe that the decoding of the proteome will impact the life sciences more than the genome revolution a decade ago, and they strive to be the company that enables the routine analysis of proteomes in each research and clinical laboratory worldwide.Biognosys offers a unique next-generation solution for precise quantification of large proteomes in biological samples. Their technology provides unprecedented depth and quality of protein expression data for more effective biomarker and drug-target discovery and validation. Biognosys is a spin-off from the leading proteomics lab of Prof. Ruedi Aebersold, ETH Zurich.

Business identity

Contact email
[email protected]
Phone number
41 44 738 20 40
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
2008-09-02

Headquarters

Postal code
8952
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
8
Total equity funding
$8M
Last funding
Series G / 2019-08-12
Last equity funding
Series G
Investors
2
Lead investors
2
Founders
1
Articles
52
Exited on
2023-01-04

Founders and investors

Founders

Oliver Rinner

Lead investors

PM Equity PartnerVenture Kick

Investors

PM Equity PartnerVenture Kick